Tag: GSK39s

FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding the vaccination's reach

The Food and Drug Administration on Friday approved GSKRespiratory syncytial virus vaccine for adults aged ...

READ MORE